EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Patient-specific iPSC-derived ECs identify QKI-7 as a key regulator of endothelial dysfunction and potential therapeutic target in diabetes

Victoria A Cornelius, Jenna Fulton, Clare Donaghy, Stuart McKeown, Hojjat Naderi-Meshkin, Shu-Dong Zhang iD, Wiwit Ananda Wahyu Setyaningsih, Andrew Yacoub, Anna Zampetaki, Alan W Stitt, Noemi Lois, David J Grieve und 1 weitere

Stem Cells Translational Medicine · 20.07.2026 · 15 (8)

DOI: 10.1093/stcltm/szag057 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Stem Cells Translational Medicine, online erschienen am 06.08.2026. Verfasst von Victoria A Cornelius und 12 weiteren Autor:innen. Beteiligte Einrichtung: The Wellcome-Wolfson Institute for Experimental Medicine, Queen's University Belfast, 97 Lisburn Road, Belfast, United Kingdom. Hauptthemen laut MEDLINE: Induced Pluripotent Stem Cells, RNA-Binding Proteins, Endothelial Cells, Endothelium, Vascular. Die Arbeit nennt 62 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: MRC, British Heart Foundation, Northern Ireland Department for the Economy.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Diabetic vascular complications remain a major cause of morbidity and mortality, yet the molecular mechanisms underlying endothelial dysfunction in diabetes remain incompletely understood. Endothelial dysfunction is a key contributor to vascular pathology, and patient-derived induced pluripotent stem cell–derived endothelial cells (iPSC-ECs) provide a human platform to investigate disease-associated endothelial phenotypes under controlled conditions. Here, we identify the RNA-binding protein Quaking-7 (QKI-7) as a key regulatory factor associated with endothelial dysfunction in patient-derived iPSC-ECs. Using cells derived from diabetic and non-diabetic donors maintained under standard culture conditions, we demonstrate that elevated QKI-7 expression is associated with reduced expression of endothelial homeostatic genes (COL4A2, JUN, TMEM184A, and PPP1R15A) and impaired angiogenic capacity, including reduced tube formation. Importantly, these findings were further validated in three-dimensional blood vessel organoid models, supporting the relevance of QKI-7–associated endothelial phenotypes in a more physiologically complex vascular system. Connectivity mapping identified FDA-approved compounds, including simvastatin, halcinonide, and retinoic acid, as potential modulators of QKI-7–associated pathways. Functional validation in iPSC-ECs demonstrated that these compounds reduce QKI-7 expression and improve endothelial functional readouts. Together, these findings identify QKI-7 as a regulatory node associated with endothelial dysfunction in patient-derived iPSC-ECs and highlight the utility of human iPSC-based vascular models for identifying candidate therapeutic strategies. While these models capture endothelial phenotypes associated with diabetic donor origin, further studies in more complex in vivo systems will be required to establish causal relevance to vascular disease.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Induced Pluripotent Stem CellsRNA-Binding ProteinsEndothelial CellsEndothelium, VascularHumansCell Differentiation

Stichwörter der Autor:innen

DiabetesQKI-7RNA-binding proteinsblood vessel organoidsdrug repurposingendothelial dysfunctioniPSC-derived endothelial cellspatient-specific iPSCsretinoic acidsimvastatinvascular biology

Substanzen

RNA-Binding Proteins

Autor:innen und Institutionen

  • The Wellcome-Wolfson Institute for Experimental Medicine, Queen's University Belfast, 97 Lisburn Road, Belfast, United Kingdom.
  • Personalised Medicine Centre, School of Medicine, Ulster University, C-TRIC Building, Altnagelvin Area Hospital, Glenshane Road, Derry-Londonderry, United Kingdom.
  • Department of Anatomy, Faculty of Medicine, Public Health, and Nursing, Universitas Gadjah Mada, Sleman, D.I. Yogyakarta 55281, Indonesia.
  • School of Cardiovascular Medicine and Sciences, BHF Centre of Research Excellence, King's College London, The James Black Centre , 125 Coldharbour Lane, London, United Kingdom.

ORCID-Profile: Shu-Dong Zhang, Andriana Margariti

Förderung

  • MRC
  • British Heart Foundation
  • Northern Ireland Department for the Economy
  • King's BHF Center of Research Excellence
  • King’s BHF Center of Research Excellence

Zitieren

APA

Cornelius, V. A., Fulton, J., Donaghy, C., McKeown, S., Naderi-Meshkin, H., Zhang, S. D., Setyaningsih, W. A. W., Yacoub, A., Zampetaki, A., Stitt, A. W., Lois, N., Grieve, D. J., & Margariti, A. (2026). Patient-specific iPSC-derived ECs identify QKI-7 as a key regulator of endothelial dysfunction and potential therapeutic target in diabetes. Stem Cells Translational Medicine, 15(8). https://doi.org/10.1093/stcltm/szag057

Vancouver

Cornelius VA, Fulton J, Donaghy C, McKeown S, Naderi-Meshkin H, Zhang SD, et al. Patient-specific iPSC-derived ECs identify QKI-7 as a key regulator of endothelial dysfunction and potential therapeutic target in diabetes. Stem Cells Translational Medicine. 2026;15(8). doi:10.1093/stcltm/szag057

BibTeX
@article{Cornelius2026,
  author = {Cornelius, Victoria A and Fulton, Jenna and Donaghy, Clare and McKeown, Stuart and Naderi-Meshkin, Hojjat and Zhang, Shu-Dong and Setyaningsih, Wiwit Ananda Wahyu and Yacoub, Andrew and Zampetaki, Anna and Stitt, Alan W and Lois, Noemi and Grieve, David J and Margariti, Andriana},
  title = {Patient-specific iPSC-derived ECs identify QKI-7 as a key regulator of endothelial dysfunction and potential therapeutic target in diabetes},
  journal = {Stem Cells Translational Medicine},
  year = {2026},
  volume = {15},
  number = {8},
  doi = {10.1093/stcltm/szag057}
}
Kostenlos starten →